Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9147 |
High Similarity |
NPD4908 |
Phase 1 |
0.9077 |
High Similarity |
NPD4625 |
Phase 3 |
0.9008 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8906 |
High Similarity |
NPD4749 |
Approved |
0.875 |
High Similarity |
NPD1610 |
Phase 2 |
0.8722 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8417 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8417 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8296 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8222 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8222 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8188 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.806 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7986 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7959 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7929 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7923 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7817 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7808 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7808 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7794 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.777 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7746 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7727 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7662 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7658 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.763 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7626 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7589 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7571 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7551 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7536 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7535 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD37 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7466 |
Intermediate Similarity |
NPD3748 |
Approved |
0.746 |
Intermediate Similarity |
NPD846 |
Approved |
0.746 |
Intermediate Similarity |
NPD940 |
Approved |
0.7452 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7452 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7426 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7424 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7424 |
Intermediate Similarity |
NPD5535 |
Approved |
0.741 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7388 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7381 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7361 |
Intermediate Similarity |
NPD7265 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7328 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2801 |
Approved |
0.731 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7308 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7302 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7262 |
Intermediate Similarity |
NPD8053 |
Approved |
0.726 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD968 |
Approved |
0.723 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7215 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3021 |
Approved |
0.719 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7143 |
Intermediate Similarity |
NPD288 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD709 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7124 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7122 |
Intermediate Similarity |
NPD17 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD2157 |
Approved |
0.709 |
Intermediate Similarity |
NPD228 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1712 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7067
|
Intermediate Similarity |
NPD2935 |
Discontinued |